Psychedelics Research Review: February 2021 Post published:March 9, 2021 Post category:Psychedelics Research Review
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity Post published:March 9, 2021 Post category:Press Release
MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study Post published:March 9, 2021 Post category:Press Release
Better Plant Appoints Branding Expert Perry Chua as Chief Creative Officer Post published:March 9, 2021 Post category:Press Release
Awakn Acquires Proprietary Next Generation MDMA and Ketamine Data from Prof. David Nutt Post published:March 9, 2021 Post category:Press Release
Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer Post published:March 9, 2021 Post category:Press Release
MindMed Announces C$19.5 Million Bought Deal Private Placement Offering Post published:March 8, 2021 Post category:Press Release
Cybin Inc. Shares Commence Trading on the OTCQB Venture Market on March 8, 2021 Post published:March 8, 2021 Post category:Press Release
Silo Wellness Kicks Off Second Oregon Psychedelic Wellness Retreat Post published:March 8, 2021 Post category:Press Release
Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands Post published:March 8, 2021 Post category:Press Release